Right Leg Pain Following Octreotide Use

Right Leg Pain Following Octreotide Use

Patient Information:

  • Initials:D.
  • Gender: Male
  • Chief Complaint: Right leg pain
  • Past Medical History: History of stomach mass, ascites, prediabetes
  • Social History: Lives alone, no family support, unable to work due to medical condition, applying for disability

SUBJECTIVE:

Chief Complaint:

“My right leg started hurting after I took octreotide.”

History of Present Illness (HPI):

The patient presents to the clinic with right leg pain that began after taking octreotide, indicating symptom onset following initiation of the medication. The pain is localized to the right leg and has continued since it first appeared. The patient reports that the discomfort is present throughout the day, becomes more noticeable with movement, and improves with rest. The pain has affected the patient’s ability to work and perform daily activities. The patient has a medical history that includes a stomach mass, ascites, and prediabetes. The patient lives alone, reports having no family support, and is currently applying for disability due to limitations related to the medical condition. No injury associated with the onset of the right leg pain was reported.

Current Medications: Octreotide

Allergies: No allergies reported by the patient

 

Past Medical History (PMH):

  • History of stomach mass
  • Ascites
  • Prediabetes

Past Surgical History (PSH): Not reported

Family History: Patient reports having no family history

Personal and Social History:

  • Lives alone
  • Unable to work due to a medical condition
  • Applying for disability benefits

Review of Systems (ROS)

  • Constitutional: Patient reports overall health concerns primarily related to right leg pain.
  • Skin/Integumentary: No skin-related concerns reported.
  • Head/Eyes/Ears/Nose/Throat (HEENT): No concerns reported with vision, hearing, nasal passages, or throat.
  • Cardiovascular: Patient reports no concerns related to heart activity or circulation.
  • Respiratory: Patient reports comfortable breathing without respiratory concerns.
  • Gastrointestinal: Patient reports a history of stomach mass and ascites with no additional concerns noted during this visit.
  • Genitourinary: No concerns reported.
  • Musculoskeletal: Patient reports right leg pain affecting movement and daily activities.
  • Neurological: Patient reports intact sensation and coordination.
  • Endocrine: Patient reports a history of prediabetes.
  • Hematologic/Lymphatic: No concerns reported.
  • Psychiatric: Patient reports managing current health-related challenges while living independently.

OBJECTIVE:

Vital Signs:

  • Blood Pressure: 128/78 mmHg
  • Heart Rate: 76 beats per minute
  • Respiratory Rate: 16 breaths per minute
  • Temperature: 98.4°F (36.9°C)
  • Oxygen Saturation: 98% on room air

General Appearance: Patient is alert, oriented, and cooperative. Ambulates with measured movements and demonstrates awareness of right leg discomfort during positional changes.

Musculoskeletal: Right lower extremity shows appropriate alignment with purposeful movement. Range of motion is observed and performed with care due to reported discomfort. Muscle tone appears symmetrical. Skin over the extremity seems intact.

Neurological: Sensation to light touch observed. Motor function is present in the bilateral lower extremities. Coordination and balance were observed during ambulation.

Cardiovascular: Heart rhythm observed as regular with a consistent rate. Peripheral pulses palpable and symmetric. Capillary refill observed within the expected timeframe.

Respiratory: Chest expansion observed as symmetrical. Breathing appears unlabored, with airflow noted throughout the lung fields.

 

 

ASSESSMENT:

Primary Diagnosis

Right leg pain associated with recent octreotide therapy

The patient reports right leg discomfort that began following initiation of octreotide. The close temporal relationship between medication use and symptom onset supports this assessment. Patient-reported symptoms and physical examination findings indicate localized discomfort with movement while strength, sensation, and circulation remain present (Debnath & Cheriyath, 2023). These findings are consistent with a medication-associated musculoskeletal response.

Differential Diagnoses

  1. Medication-related musculoskeletal discomfort
  2. Octreotide has been associated with musculoskeletal symptoms in some individuals. The timing of symptom onset following medication initiation supports this as a contributing consideration (Koobatian et al., 2025).
  3. Peripheral neuropathic discomfort
  4. Given the patient’s history of prediabetes, peripheral nerve involvement is considered. Sensory and motor function observed during examination support continued monitoring of this possibility (Riahi et al., 2025).
  5. Mechanical muscle strain
  6. Daily activities and movement patterns may contribute to localized leg discomfort. Observed range of motion and muscle tone support this as a potential contributing factor (Stožer et al., 2020).

Additional Active Conditions

  • History of stomach mass with ascites
  • Prediabetes

These conditions remain clinically relevant and are considered in overall care planning and functional assessment.

PLAN:

Treatment and Management

  • Provided guided therapeutic exercises for the right leg to support comfort, mobility, and flexibility
  • Encouraged gradual participation in activities within personal tolerance to support functional movement
  • Discussed body mechanics and positioning to support daily activities

Pharmacological Management

  • No new medications were initiated during this visit
  • Continue the current medication regimen as prescribed
  • Encouraged discussion of medication response with the Primary Care Provider

Diagnostics: No laboratory tests or imaging studies indicated at this time based on the current presentation

Referrals and Follow-Up

  • Recommended follow-up with the Primary Care Provider for continued evaluation and coordination of care
  • Encouraged ongoing communication regarding symptom progression and medication management

 Health Promotion

  • Discussed the role of gentle physical activity and regular movement in supporting musculoskeletal health
  • Encouraged balanced nutrition and hydration to support overall wellness and metabolic health

Disease Prevention

  • Reinforced adherence to routine preventive care appropriate to health history
  • Encouraged continued monitoring of blood glucose levels as directed to support prediabetes management

Patient Education

  • Provided education on recognizing body responses to activity and medication
  • Patient expressed understanding and engagement in care planning

Follow-Up Instructions

  • Patient encouraged to attend scheduled follow-up and to communicate with healthcare providers regarding changes in symptoms.

Reflection

This patient visit boosted my knowledge regarding the need to evaluate patient-reported symptoms carefully concerning the new medications. The assessment of the time-dependence between the beginning of treatment and the emergence of new physical issues supported the importance of a detailed history-taking and active listening. This experience underscored the role of musculoskeletal symptoms in determining functional ability and functioning in terms of daily activities, especially in the management of multiple chronic conditions. In case of a similar incident in the future, I would still focus on the early interdisciplinary communication, especially with the primary care provider, so that there would be coordination of medication administration and monitoring of symptoms. The interaction also reinforced my values regarding the inclusion of social factors, including lack of support systems and employment issues, into patient-centered care.

I found the clinical recommendations given in the present visit agreeable and in line with evidence-based practice because they were patient-focused on safety and comfort, and continuity of care. Additional supportive services, like physical therapy referrals, are also more accessible to patients who have insurance coverage. Community-based resources and home exercise programs are also practical alternatives for patients without insurance to maintain care and improve their functional status. This experience strengthened the principle of holistic evaluation, effective patient education, and personal care planning in achieving favorable health outcomes.

References

Debnath, D., & Cheriyath, P. (2023, May 1). Octreotide. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK544333/

Koobatian, M., Sisco, J., Okeyo, J. C., Krasner, A., & Quock, T. P. (2025). Real-world burden of disease, treatment, and healthcare resource utilization in acromegaly: a quantitative survey of patient experiences. Journal of Patient-Reported Outcomes, 9(1), 140. https://doi.org/10.1186/s41687-025-00965-3

Riahi, R., Seindareh, S., Aminorroaya, A., Ghasemi, M., Mehvari, J., & Maracy, M. R. (2025). The Relationship Between Prediabetes and Peripheral Neuropathy—A Systematic Review and Meta-Analysis. Wiley Online Library. https://doi.org/10.1111/ene.70283

Stožer, A., Vodopivc, P., & Bombek, L. K. (2020). Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences. Physiological Research, 69(4), 565–598. https://doi.org/10.33549/physiolres.934371

 

 

 

CLICK HERE TO ORDER A PLAGIARISM – FREE PAPER

Question:
How does the temporal relationship between the initiation of Octreotide therapy and the onset of right leg pain in patient J.D. support the primary diagnosis, and what differential diagnoses should be considered given the patient’s history of prediabetes and current clinical presentation?

If you want, I can also generate multiple questions (e.g., for discussion, exams, or SOAP note reflection).